Cervarix is a vaccine approved by the U.S. Food and Drug Administration (FDA) to help protect against cervical cancer and precancers caused by human papillomavirus (HPV) types 16 and 18. There are many types of HPV but only certain types cause cervical cancer. HPV types 16 and 18 are the two most common types of HPV that lead to cervical cancer and precancers.
Cervarix is approved for use by girls and women 9 through 25 years of age.
The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, prepared by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the HIV Medicine Association of the Infectious Diseases Society of America (IDSA-HIVMA), includes recommendations on the use of Cervarix in HIV-infected individuals.
Before receiving Cervarix, tell your health care provider:
Ask your health care provider about possible side effects from Cervarix. Your health care provider will tell you what to do if you have side effects.
A health care provider gives the Cervarix vaccine. The vaccine is given as an injection (shot) in a muscle in your arm. Vaccination with Cervarix is usually given as a series of 3 vaccine shots over a 6-month period. Read any printed information that your health care provider gives you about the HPV vaccine.
More information about HPV vaccines is available:
Last Reviewed: September 11, 2015